CDPH Weekly COVID-19 Update
Chicago’s COVID-19 Risk Level Remains Low and COVID-19 Treatments Are More Widely Available
The Chicago Department of Public Health (CDPH) reported weekly COVID-19 statistics today and said the city continues to remain in the Low-Risk category on the Centers for Disease Control’s (CDC’s) COVID-19 Community Levels index. Test positivity rates are coming down after a brief increase caused by a testing decline while many schools were on spring break. Severe outcomes in Chicago, including both COVID-19 hospitalizations and COVID-19 deaths, continue to remain at or near all-time pandemic lows.
CDPH also said that treatments for people with COVID-19 who are at increased risk for severe outcomes are now more widely available than ever, including for the first time, children. Early outpatient treatment of COVID-19 can avert serious, potentially life-threatening illness.
Earlier in the year, some COVID-19 therapeutics were in short supply. Now antivirals for COVID-19 are widely available and can be accessed with a provider prescription at pharmacies nationwide and at locations. Yesterday, the FDA expanded approval of one of the treatments, remdesivir, to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds). If you test positive for COVID-19, including on a home test, contact your healthcare provider right away to discuss treatment options.
“COVID is not gone, – and may never be gone – but I remain pleased with Chicago’s current position at this stage of the pandemic,” said Allison Arwady, M.D., Commissioner of CDPH. “Our risk level remains low, daily case counts are increasing only gradually, and our hospital and healthcare system has plenty of capacity. We have the right tools in our toolbox to prevent severe illness and death from COVID-19 including vaccination and treatments — more available and accessible than ever.”